Invesco India Contra Fund - Growth - Regular Plan

Other Plans and Options
  • (-0.92%)Nav, as on 27-02-2025

  • Previous Nav

  • Net Change on 27-02-2025

  • PersonalFN Rating

  • Assets (Cr.)

  • Expense Ratio

Fund Overview Growth | Regular Plan

  • Fund House

  • Launch Date

  • Benchmark

  • Minimum Investment (₹)

  • Minimum Addl Investment (₹)

  • Exit Load (%)

  • Minimum SIP Investment (₹)

  • Minimum STP Investment (₹)

  • Minimum SWP Investment (₹)

  • 52 Week Low Nav (₹)

  • 52 Week Low Nav Date

  • 52 Week High Nav (₹)

  • 52 Week High Nav Date

Fund Objective

To generate capital appreciation by investing predominantly in Equity and Equity Related Instruments through contrarian investing.

Fund Performance

Scheme Name 1-Month Return (%) 3-Month Return (%) 1-Year Return (%) 3-Year Return (%) 5-Year Return (%) Since Inception
Invesco India Contra Fund - Growth -3.48 -12.31 8.30 17.53 18.66 14.79
BSE 500 - TRI -4.82 -11.56 0.02 12.64 17.90 11.34
NIFTY 50 - TRI N/A N/A N/A N/A N/A N/A

Returns upto 1 year is Absolute, and above 1 year are Compounded Annualised

Peer Fund Comparison

Scheme Name Launch Date Ratings 1-Year Return (%) 3-Year Return (%) 5-Year Return (%) Expense Ratio (%) Assets (Cr.)
Invesco India Contra Fund - Growth Apr 11, 2007 8.30 17.53 18.66 1.66 17,167.52
SBI CONTRA FUND - REGULAR PLAN -GROWTH Jul 05, 1999 3.21 21.76 27.61 1.52 41,634.25
Kotak India EQ Contra Fund - Growth Jul 27, 2005 1.91 18.00 18.98 1.88 3,845.07

Fund Holdings as on 31-January-2025

  • HDFC Bank Limited

  • ICICI Bank Limited

  • Infosys Limited

  • Triparty Repo

  • Axis Bank Limited

  • Mahindra & Mahindra Limited

  • Larsen & Toubro Limited

  • NTPC Limited

  • Apollo Hospitals Enterprise Limited

  • Bharat Electronics Limited

  • REC Limited

  • Zomato Limited

  • Coforge Limited

  • Kotak Mahindra Bank Limited

  • Bharti Airtel Ltd Partly Paid 1.25 FV

  • LTIMindtree Limited

  • The Federal Bank Limited

  • Mankind Pharma Limited

  • Britannia Industries Limited

  • Cholamandalam Investment and Finance Company Limited

  • ICICI Lombard General Insurance Company Limited

  • Hindustan Petroleum Corporation Limited

  • Prestige Estates Projects Limited

  • Avenue Supermarts Limited

  • FSN E-Commerce Ventures Limited ‡

  • Glenmark Pharmaceuticals Limited

  • Lupin Limited

  • TVS Motor Company Limited

  • Entero Healthcare Solutions Ltd

  • Ajanta Pharma Limited

  • Divi's Laboratories Limited

  • Ambuja Cements Limited

  • Honeywell Automation India Limited

  • Shyam Metalics and Energy Limited

  • Multi Commodity Exchange of India Limited

  • Suven Pharmaceuticals Limited

  • Jyoti CNC Automation Ltd

  • Orchid Pharma Limited

  • Samvardhana Motherson International Limited

  • Aditya Birla Real Estate Limited

  • Jubilant Foodworks Limited February 2025 Future

  • Devyani International Limited

  • ITC Limited

  • PI Industries Limited

  • Suzlon Energy Limited

  • Kalyan Jewellers India Limited

  • BSE Limited

  • SBI Life Insurance Company Limited

  • Whirlpool of India Limited

  • Crompton Greaves Consumer Electricals Limited

  • Central Depository Services (India) Limited

  • Craftsman Automation Limited

  • KEI Industries Limited

  • J B Chemicals and Pharma Ltd

  • Equitas Small Finance Bank Limited

  • Global Health Limited

  • Jubilant Foodworks Limited

  • Tata Power Company Limited

  • V-Mart Retail Limited

  • Deepak Nitrite Limited

  • Voltas Limited

  • Aadhar Housing Finance Limited

  • MedPlus Health Services Limited

  • Asian Paints Limited February 2025 Future

  • Zinka Logistics Solution Limited

  • Sonata Software Limited

  • Delhivery Limited ‡

  • Wockhardt Limited

  • Asian Paints Limited

  • Gland Pharma Limited

  • Lupin Limited February 2025 Future

  • Info Edge (India) Limited

  • REC Limited February 2025 Future

  • Hindustan Petroleum Corporation Limited February 2025 Future

  • Larsen & Toubro Limited February 2025 Future

  • Crompton Greaves Consumer Electricals Limited February 2025 Future

  • ITC Hotels Limited

  • Glenmark Pharmaceuticals Limited February 2025 Future

  • Net Receivables / (Payables)

View More

  • Bank - Private

  • IT - Software

  • Pharmaceuticals & Drugs

  • e-Commerce

  • Hospital & Healthcare Services

  • Power Generation/Distribution

  • Consumer Food

  • Automobiles - Passenger Cars

  • Engineering - Construction

  • Defence

  • Miscellaneous

  • Finance Term Lending

  • Insurance

  • Retailing

  • Auto Ancillary

  • Finance - NBFC

  • Consumer Durables - Domestic Appliances

  • Construction - Real Estate

  • Refineries

  • Automobile Two & Three Wheelers

  • Trading

  • Cement & Construction Materials

  • Consumer Durables - Electronics

  • Steel & Iron Products

  • Finance - Stock Broking

  • Engineering - Industrial Equipments

  • Diversified

  • Cigarettes/Tobacco

  • Pesticides & Agrochemicals

  • Electric Equipment

  • Diamond & Jewellery

  • Finance - Others

  • Depository Services

  • Cable

  • Chemicals

  • Air Conditioners

  • Finance - Housing

  • Logistics

  • Courier Services

  • Paints

  • BPO/ITeS

  • Hotel, Resort & Restaurants

View More

Fund Manager

  • Cash

  • Derivatives

  • Equity

  • Rights

View More

About Invesco India Contra Fund

Scheme Analysis

Invesco India Contra Fund is a Equity - Contra Fund fund and belongs to Invesco Mutual Fund. It was launched on 11-Apr-2007 and currently has an AUM of ₹17,167.52 crore. Invesco India Contra Fund is benchmarked against BSE 500 - TRI as primary index and NIFTY 50 - TRI as secondary index.

The NAV of Invesco India Contra Fund ended down ₹-1.09(-0.92%)yesterday to ₹117.99.

Among its top 3 holdings the fund has exposure to HDFC Bank Limited, and

The Invesco India Contra Fund is managed by Amit Ganatra and Taher Badshah.

Fund House Contact

2101-A, A Wing, 21st Floor, Marathon Futurex, N. M. Joshi Marg, Lower Parel Mumbai - 400 013

022 - 67310000
mfservice@religare.com
022 - 23019422